PHARMACEUTICAL COMPOSITIONS CONTAINING LYSOSTAPHIN ALONE OR IN COMBINATION WITH AN ANTIBIOTIC FOR THE TREATMENT OF STAPHYLOCOCCAL INFECTIONS

摘要

Lysostaphin is demonstrated to be a powerful ani-staphylococcal agent suitable for parental administration to mammals including humans. Low dosages, on the order of 0.5 - 45 mg/kg/day are sufficient to eradicate most staphylococcal infections. Lysostaphin is also effective against bacteria of this type which have developed resistance to conventional antibiotics such as penicillins and vancomycin. Lysostaphin analogues, such as variants and related enzymes, show similar activity.